U.S. markets open in 6 hours 29 minutes

Daxor Corporation (DXR)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
11.50-0.18 (-1.56%)
At close: 9:30AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close11.68
Open11.50
Bid11.19 x 900
Ask0.00 x 1300
Day's Range11.50 - 11.50
52 Week Range8.58 - 17.58
Volume242
Avg. Volume27,803
Market Cap46.39M
Beta (5Y Monthly)-1.09
PE Ratio (TTM)157.53
EPS (TTM)0.07
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJan 05, 2018
1y Target Est22.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-28% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Daxor Corporation
    Analyst Report: Edwards Lifesciences CorporationSpun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.
    Rating
    Fair Value
    Economic Moat
    5 months agoMorningstar
View more